| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 12/31/2009 | US20090326058 CaSR Antagonist |
| 12/31/2009 | US20090325980 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325930 Selective estrogen receptor modulator |
| 12/31/2009 | US20090325908 9-substituted minocycline compounds |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/30/2009 | WO2009158467A2 Di-substituted phenyl compounds |
| 12/30/2009 | WO2009156889A1 Diaryl compounds and uses thereof |
| 12/30/2009 | EP2138487A1 Substituted morpholine and thiomorpholine derivatives for the treatment of bipolar disorders |
| 12/30/2009 | EP2137173A2 Process for the preparation of piperazine benzothiazoles |
| 12/30/2009 | CN101613327A Device for protecting morpholine catalyst and production process thereof |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/30/2009 | CA2729220A1 Di-substituted phenyl compounds |
| 12/29/2009 | US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents |
| 12/29/2009 | US7638627 Imatinib hydrochloride; reacting N-(2-methyl-5-aminophenyl-4-(3-pyridyl)-2-pyrimidineamine with 4-(4-methyl-piperazinomethyl)benzoyl chloride; improved reduction step to simplify, increase yield, improve purity |
| 12/29/2009 | US7638550 new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to their inhibitory activity on certain histone deacetylases. |
| 12/29/2009 | US7638514 Agriculture |
| 12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
| 12/29/2009 | US7638512 Phenylaminopropanol derivatives and methods of their use |
| 12/29/2009 | US7638118 But-2-enedioic acid 2-(2-dimethylamino-ethoxy)-ethyl ester ethyl ester; but-2-enedioic acid bis-[2-(2-dimethylamino-ethoxy)-ethyl]ester; 3-[bis-(3-dimethylamino-propyl)-carbamoyl]-acrylic acid ethyl ester; deodorant or an antiperspirant |
| 12/29/2009 | CA2477851C Small molecule entry inhibitors |
| 12/29/2009 | CA2393183C Process for the preparation of 5-(1-piperazinyl)benzofuran-2-carboxamide by transition metal-catalysed amination |
| 12/29/2009 | CA2390296C Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine |
| 12/23/2009 | WO2009155386A1 A process for the preparation of the apoptosis promoter abt-263 |
| 12/23/2009 | WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses |
| 12/23/2009 | WO2009154783A2 Synthesis and use of mse-framework type molecular sieves |
| 12/23/2009 | WO2009154754A2 Synthesis of deuterated morpholine derivatives |
| 12/23/2009 | WO2009153651A1 Process for preparing a piperazine derivative |
| 12/23/2009 | WO2009153514A1 Phenyl-alkyl piperazines having a modulating activity of tnf |
| 12/23/2009 | WO2009152906A2 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
| 12/23/2009 | EP2135859A2 Liquid electrolytes comprising ionic liquids, and their use in electrical storage devices |
| 12/23/2009 | EP2134687A1 Piperazine and piperidine mglur5 potentiators |
| 12/23/2009 | EP1664007B1 Preparation of quetiapine |
| 12/23/2009 | EP1506169B1 Method for the production of sulphonic acid diamides |
| 12/23/2009 | CN101611021A Organic molybdenum compounds and oil compositions containing the same |
| 12/23/2009 | CN101610997A Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 12/23/2009 | CN101610813A Quinuclidinol derivatives as muscarinic receptor antagonists |
| 12/23/2009 | CN101607718A Method for recycling ammonia from raw morpholine |
| 12/23/2009 | CN101607717A Liquid ammonia material for preparing morpholine |
| 12/23/2009 | CA2727932A1 A process for the preparation of the apoptosis promoter abt-263 |
| 12/23/2009 | CA2727911A1 Phenyl-alkyl piperazines having a modulating activity of tnf |
| 12/23/2009 | CA2726816A1 Synthesis and use of mse-framework type molecular sieves |
| 12/22/2009 | US7635698 Compounds useful as chemokine receptor antagonists |
| 12/22/2009 | US7635697 e.g. 3-Bromo-8,11-dichloro-6,11-dihydro[5,6]cyclohepta[1,2-b]pyridine deivative; anticarcinogenic agents |
| 12/22/2009 | CA2352937C Process for producing n-acylnitroaniline derivative |
| 12/22/2009 | CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 12/17/2009 | WO2009150248A1 Compounds which can be used for the treatment of cancers |
| 12/17/2009 | WO2009150147A1 New process for the preparation of levocetirizine and intermediates thereof |
| 12/17/2009 | WO2009150129A1 Heterocyclic derivatives as hdac inhibitors |
| 12/17/2009 | US20090312392 Amino ceramide-like compounds and therapeutic methods of use |
| 12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
| 12/17/2009 | US20090312328 Sulfonamide compound or salt thereof |
| 12/17/2009 | US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3 |
| 12/17/2009 | CA2727296A1 Compounds which can be used for the treatment of cancers |
| 12/17/2009 | CA2726158A1 Compounds and compositions useful for the treatment of malaria |
| 12/16/2009 | EP2133334A1 Heterocyclic derivatives as HDAC inhibitors |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | EP2132174A1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors |
| 12/16/2009 | EP2131845A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 12/16/2009 | EP1619180B1 CaSR ANTAGONIST |
| 12/16/2009 | CN101602783A Piperazine alkyl bridged linkage bis aryloxy rare earth metal alkyl compound and application thereof |
| 12/16/2009 | CN101602752A N-sulfenamide group-N'-tert-butyl group-N and N'-diaryl hydrazide compound as well as preparation method and application thereof |
| 12/16/2009 | CN101602751A Preparation method of cinepazide maleate |
| 12/16/2009 | CN101602750A (Substituted) naphthyl, (substituted) aryl, piperazinyl amidine compound |
| 12/16/2009 | CN101602749A Novel method for purifying piperidine product |
| 12/16/2009 | CN101602748A Method for purifying high-purity piperidine |
| 12/16/2009 | CN101602687A 6-nitroacetophenone compound, preparation method and application thereof |
| 12/16/2009 | CN101601984A Nonylphenol polyoxyethylene ether dimeric surfactant using piperazine as connecting group |
| 12/16/2009 | CN100569747C Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 12/16/2009 | CN100569738C Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 12/15/2009 | US7632846 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
| 12/15/2009 | US7632838 11-beta HSD1 inhibitors |
| 12/15/2009 | US7632835 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide; potent openers of the KCNQ family of potassium ion channels; antiepileptic agents; anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders |
| 12/10/2009 | WO2009148046A1 Method of producing optically active amino acid derivative |
| 12/10/2009 | WO2009147831A1 Method and pharmaceutical composition for treatment of mental disorders |
| 12/10/2009 | WO2009147389A2 Processes for the synthesis of levocetirizine and intermediates for use therein |
| 12/10/2009 | WO2009147221A1 Small molecule leptin receptor modulators |
| 12/10/2009 | WO2009147149A1 Compounds comprising a cyclobutoxy group |
| 12/10/2009 | WO2009147057A1 Polymerizable type ii photoinitiators and curable compositions |
| 12/10/2009 | WO2009147054A1 Multifunctional type ii photoinitiators and curable compositions |
| 12/10/2009 | WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/10/2009 | US20090306134 Muscarinic receptor antagonists |
| 12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090306078 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |
| 12/10/2009 | US20090306077 Novel n- (2-aminophenyl) benzamide derivative having urea structure |
| 12/10/2009 | US20090306022 7-substituted tetracycline compounds |
| 12/10/2009 | CA2726270A1 Small molecule leptin receptor modulators |
| 12/10/2009 | CA2724887A1 Processes for the synthesis of levocetirizine and intermediates for use therein |
| 12/10/2009 | CA2723626A1 Compounds comprising a cyclobutoxy group |
| 12/10/2009 | CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/09/2009 | EP2130825A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof |
| 12/09/2009 | EP2130818A1 Multifunctional Type II photoinitiators and curable compositions |
| 12/09/2009 | EP2130817A1 Polymerizable Type II photoinitiators and curable compositions |
| 12/09/2009 | EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450 |
| 12/09/2009 | EP2129659A1 Alpha-hydroxyketones |
| 12/09/2009 | EP2129651A2 Novel method for producing teta by means of eddn |
| 12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 12/09/2009 | CN100567279C Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 12/09/2009 | CN100567278C Benzoyl guanidine derivative, preparation method and medical use thereof |